Kolexia
Dupont-Bierre Eric Chirurgie viscérale
Dupont-Bierre Eric
Chirurgie viscérale
Selarl De Chirurgie Digestive
Saint-Grégoire, France
21 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Métastase tumorale Tumeurs colorectales Tumeurs du foie Bévacizumab Oxaliplatine Cétuximab Fluorouracil Leucovorine Panitumumab

Collaborateurs

Voir plus
Boige Valerie
Boige Valerie
Gustave-Roussy, Villejuif, France
Pignon Jean-Pierre
Pignon Jean-Pierre
Gustave-Roussy, Villejuif, France
Guimbaud Rosine
Guimbaud Rosine
Hôpital Rangueil, Toulouse, France
Miglianico Laurent
Miglianico Laurent
Clinique De La Cote D'emeraude, Saint-Malo, France

Industries

Voir plus
VIATRIS MEDICAL
1 collaboration(s)
Dernière en 2022
Janssen
1 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial.
European journal of cancer (Oxford, England : 1990)   28 octobre 2023
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment.
Cancer treatment and research communications   16 décembre 2022
SULTAN: A Randomized Phase II Study Comparing Treatment Intensification With CIAH Plus Systemic Chemotherapy to Systemic Chemotherapy Alone in Patients With Liver-only Colorectal Metastases Considered Still Non Resectable After at Least Two Months of Systemic Induction Chemotherapy
Essai Clinique (Unicancer)   03 janvier 2022
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
BMC cancer   30 janvier 2020
PRODIGE 53-UCGI 30 (SULTAN): A randomized phase II study comparing treatment intensification with hepatic arterial infusion chemotherapy plus systemic chemotherapy to systemic chemotherapy alone in patients with liver-only colorectal metastases considered still non resectable after at least two months of systemic induction chemotherapy.
2019 ASCO Annual Meeting I   26 mai 2019
Phase 2 of intra-arterial hepatic (IAH) bevacizumab with systemic chemotherapy (CT) in second line treatment of liver metastases of colorectal cancer (LMCRC)
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016
Phase 2 of intra-arterial hepatic (IAH) bevacizumab with systemic chemotherapy (CT) in second line treatment of liver metastases of colorectal cancer (LMCRC).
2016 ASCO Annual Meeting I   20 mai 2016
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}